Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Even after more than 50 MMPl-icenses we still have the same share price trouble
Reply New Message
Back To Forum List View
Even after more than 50 MMPl-icenses we still have the same share price trouble
1
s402005
May 13, 2009 05:57AM
Re: Even after more than 50 MMPl-icenses we still have the same share price trouble
2
jldmt
May 13, 2009 06:07AM

Also, the market remembers the last 10Q in which a company paid $250K for a license. License signings will no longer cause any blips in the SP unless the 10Qs start showing some meaningful revenue from license signings.

6 Recommendations
Re: Even after more than 50 MMPl-icenses we still have the same share price trouble
3
BUSHleague
May 13, 2009 06:34AM
Re: Even after more than 50 MMPl-icenses Bush
1
Sedley
May 13, 2009 06:47AM
Re: Even after more than 50 MMPl-icenses Bush
1
BUSHleague
May 13, 2009 07:00AM
Re: Even after more than 50 MMPl-icenses BUSHleague
2
patientman
May 13, 2009 07:03AM
Re: Even after more than 50 MMPl-icenses we still have the same share price trouble
1
pacard
May 13, 2009 03:42PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply